Grantham, Mayo, Van Otterloo & Co (GMO)’s Veradigm Inc. Common Stock MDRX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,700	Closed	-$436K	–	775
2022 Q4	$436K	Sell	24,700 -113,500	-82%	-$1.9M	﹤0.01%	600
2022 Q3	$2.1M	Sell	138,200 -283,400	-67%	-$4.58M	0.01%	415
2022 Q2	$6.25M	Buy	421,600 +112,400	+36%	+$2.1M	0.03%	321
2022 Q1	$6.96M	Buy	+309,200	New	+$6.26M	0.03%	313
2020 Q4	–	Sell	-312,300	Closed	-$2.54M	–	899
2020 Q3	$2.54M	Sell	312,300 -86,500	-22%	-$707K	0.02%	366
2020 Q2	$2.7M	Buy	398,800 +388,300	+3,698%	+$2.52M	0.02%	357
2020 Q1	$74K	Buy	+10,500	New	+$85.2K	﹤0.01%	733

Other funds holding MDRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MDRX Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2023, closing a stake of 24,700 shares — an estimated $436K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MDRX in Q1 2020 and held it in 7 quarters. The position peaked at $6.96M in Q1 2022. 242 funds tracked by Wall St. Rank hold MDRX as of Q1 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Veradigm Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 24,700 Veradigm Inc. Common Stock shares in Q1 2023, an estimated $436K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Veradigm Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Veradigm Inc. Common Stock position peaked at $6.96M in Q1 2022.
242 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.